{"id":"W2791185607","doi":"10.2196/resprot.8655","title":"Treatment with Creatine Monohydrate in Spinal and Bulbar Muscular Atrophy: Protocol for a Randomized, Double-Blind, Placebo-Controlled Trial","year":2018,"lang":"en","type":"article","venue":"JMIR Research Protocols","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Core Research for Evolutional Science and Technology; Daiichi Sankyo Europe; Japan Science and Technology Agency; Japan Society for the Promotion of Science; Daiichi Sankyo Foundation of Life Science","keywords":"Spinal and bulbar muscular atrophy; Medicine; Spinal muscular atrophy; Atrophy; Motor neuron; Placebo; Creatine; Physical therapy; Physical medicine and rehabilitation; Disease; Weakness; Skeletal muscle; Neuromuscular disease; Internal medicine; Pathology; Anatomy; Alternative medicine; Prostate cancer","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"protocol","about_ca_system":false,"about_ca_topic":false,"confidence":"high","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"protocol","about_ca_system":false,"about_ca_topic":false,"confidence":"high","status":"direct model label, unvalidated"}],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01614312,0.005724012,0.01118487,0.001744881,0.003208171,0.00301831,0.003460048,0.007334524,0.04971998],"category_scores_gemma":[0.01642462,0.002330086,0.003909723,0.002263625,0.003139856,0.002789554,0.001537913,0.007218749,0.009198625],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002814925,"about_ca_system_score_gemma":0.0098447,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001560141,"about_ca_topic_score_gemma":0.003987071,"domain_scores_codex":[0.9895239,0.005905657,0.001062332,0.001188508,0.001014937,0.001304651],"domain_scores_gemma":[0.9917296,0.001732665,0.001699003,0.001024321,0.00207856,0.001735902],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9636037,0.01219014,0.0002852902,0.004749869,0.0009385648,0.0000900505,0.00009574369,0.0005570836,0.001513432,0.000766783,0.004821518,0.01038766],"study_design_scores_gemma":[0.9798518,0.01393523,0.000395595,0.0003372883,0.0002311854,0.00001622318,0.0000169652,0.0003519866,0.0001416509,0.0002917562,0.004408357,0.00002198907],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"protocol","genre_gemma":"protocol","genre_scores_codex":[0.008094454,0.0007681309,0.001670095,0.0004535364,0.0008555829,0.9848495,0.001391766,0.0002018555,0.001715124],"genre_scores_gemma":[0.01008168,0.0004522152,0.002394298,0.0005255773,0.0002004711,0.9848869,0.0003563051,0.00001171606,0.001090759],"genre_candidate":"protocol","genre_consensus":"protocol","teacher_disagreement_score":0.04971998,"threshold_uncertainty_score":0.1663299,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2158363808936192,"score_gpt":0.5363328649982085,"score_spread":0.3204964841045894,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}